Grupa Azoty Past Earnings Performance
Past criteria checks 0/6
Grupa Azoty's earnings have been declining at an average annual rate of -36.3%, while the Chemicals industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 15.8% per year.
Key information
-36.3%
Earnings growth rate
-36.2%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 15.8% |
| Return on equity | -50.9% |
| Net Margin | -20.8% |
| Next Earnings Update | 22 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Grupa Azoty makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 13,545 | -2,822 | 1,960 | 0 |
| 30 Sep 23 | 15,564 | -2,621 | 2,044 | 0 |
| 30 Jun 23 | 18,802 | -2,015 | 2,027 | 0 |
| 31 Mar 23 | 21,722 | -755 | 2,126 | 0 |
| 31 Dec 22 | 24,653 | 620 | 2,144 | 0 |
| 30 Sep 22 | 25,030 | 1,856 | 2,091 | 0 |
| 30 Jun 22 | 22,599 | 1,921 | 2,064 | 0 |
| 31 Mar 22 | 19,361 | 1,348 | 1,960 | 0 |
| 31 Dec 21 | 15,896 | 582 | 1,886 | 0 |
| 30 Sep 21 | 13,148 | 327 | 1,816 | 0 |
| 30 Jun 21 | 11,682 | 347 | 1,733 | 0 |
| 31 Mar 21 | 10,778 | 248 | 1,709 | 0 |
| 31 Dec 20 | 10,520 | 312 | 1,720 | 0 |
| 30 Sep 20 | 10,426 | 215 | 1,753 | 0 |
| 30 Jun 20 | 10,574 | 256 | 1,792 | 0 |
| 31 Mar 20 | 11,042 | 244 | 1,804 | 0 |
| 31 Dec 19 | 11,304 | 373 | 1,789 | 0 |
| 30 Sep 19 | 11,445 | 376 | 1,741 | 0 |
| 30 Jun 19 | 11,205 | 199 | 1,663 | 0 |
| 31 Mar 19 | 10,852 | 118 | 1,576 | 0 |
| 31 Dec 18 | 9,980 | 10 | 1,471 | 0 |
| 30 Sep 18 | 9,731 | 72 | 1,442 | 0 |
| 30 Jun 18 | 9,602 | 245 | 1,442 | 0 |
| 31 Mar 18 | 9,406 | 398 | 1,417 | 0 |
| 31 Dec 17 | 9,595 | 457 | 1,431 | 0 |
| 30 Sep 17 | 9,376 | 385 | 1,401 | 0 |
| 30 Jun 17 | 9,180 | 321 | 1,368 | 0 |
| 31 Mar 17 | 9,154 | 261 | 1,408 | 0 |
| 31 Dec 16 | 8,944 | 302 | 1,397 | 0 |
| 30 Sep 16 | 9,102 | 448 | 1,390 | 0 |
| 30 Jun 16 | 9,499 | 518 | 1,412 | 0 |
| 31 Mar 16 | 9,620 | 601 | 1,376 | 0 |
| 31 Dec 15 | 9,975 | 605 | 1,367 | 0 |
| 30 Sep 15 | 10,030 | 491 | 1,373 | 0 |
| 30 Jun 15 | 9,903 | 422 | 1,359 | 0 |
| 31 Mar 15 | 9,995 | 372 | 1,346 | 0 |
| 31 Dec 14 | 9,865 | 232 | 1,321 | 0 |
| 30 Sep 14 | 9,657 | 170 | 1,288 | 0 |
| 30 Jun 14 | 9,614 | 162 | 1,241 | 0 |
| 31 Mar 14 | 9,807 | 435 | 1,204 | 0 |
| 31 Dec 13 | 9,788 | 678 | 1,149 | 0 |
| 30 Sep 13 | 9,041 | 756 | 964 | 0 |
| 30 Jun 13 | 8,512 | 771 | 843 | 0 |
Quality Earnings: 0NS1 is currently unprofitable.
Growing Profit Margin: 0NS1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0NS1 is unprofitable, and losses have increased over the past 5 years at a rate of 36.3% per year.
Accelerating Growth: Unable to compare 0NS1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0NS1 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.4%).
Return on Equity
High ROE: 0NS1 has a negative Return on Equity (-50.87%), as it is currently unprofitable.